Short Interest in First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) Drops By 56.2%

First Trust NYSE Arca Biotechnology Index Fund (NYSEARCA:FBT) was the recipient of a significant decrease in short interest during the month of January. As of January 30th, there was short interest totaling 24,107 shares, a decrease of 56.2% from the January 15th total of 55,046 shares. Currently, 2.3% of the shares of the stock are sold short. Based on an average daily trading volume, of 817,638 shares, the days-to-cover ratio is presently 0.0 days. Based on an average daily trading volume, of 817,638 shares, the days-to-cover ratio is presently 0.0 days. Currently, 2.3% of the shares of the stock are sold short.

Institutional Trading of First Trust NYSE Arca Biotechnology Index Fund

Large investors have recently made changes to their positions in the business. Jacobi Capital Management LLC bought a new position in shares of First Trust NYSE Arca Biotechnology Index Fund in the fourth quarter valued at about $289,000. Kestra Advisory Services LLC increased its position in First Trust NYSE Arca Biotechnology Index Fund by 68.8% in the 4th quarter. Kestra Advisory Services LLC now owns 30,277 shares of the company’s stock valued at $6,253,000 after acquiring an additional 12,344 shares in the last quarter. 360 Financial Inc. acquired a new stake in First Trust NYSE Arca Biotechnology Index Fund in the 4th quarter valued at about $14,887,000. Stifel Financial Corp raised its stake in shares of First Trust NYSE Arca Biotechnology Index Fund by 16.4% in the fourth quarter. Stifel Financial Corp now owns 60,446 shares of the company’s stock worth $12,484,000 after acquiring an additional 8,508 shares during the last quarter. Finally, Commerce Bank acquired a new position in shares of First Trust NYSE Arca Biotechnology Index Fund during the fourth quarter worth approximately $207,000.

First Trust NYSE Arca Biotechnology Index Fund Price Performance

Shares of NYSEARCA:FBT traded up $2.92 during trading on Friday, reaching $207.88. The stock had a trading volume of 211,064 shares, compared to its average volume of 310,112. The stock has a market capitalization of $218.27 million, a PE ratio of 21.72 and a beta of 0.65. First Trust NYSE Arca Biotechnology Index Fund has a 52 week low of $141.38 and a 52 week high of $224.94. The business’s 50-day moving average price is $212.38 and its 200 day moving average price is $194.58.

First Trust NYSE Arca Biotechnology Index Fund Company Profile

The First Trust NYSE Arca Biotechnology Index Fund (FBT) is an exchange-traded fund that is based on the NYSE Arca Biotechnology index. The fund tracks an equal-weighted index of US biotechnology stocks. FBT was launched on Jun 19, 2006 and is managed by First Trust.